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Abstract
The protozoan parasites Leishmania,  Trypanosoma cruzi and Trypanosoma brucei show multiple
features consistent with a form of programmed cell death (PCD). Despite some similarities with
apoptosis of mammalian cells, PCD in trypanosomatid protozoans appears to be significantly
different. In these unicellular organisms, PCD could represent an altruistic mechanism for the
selection of cells, from the parasite population, that are fit to be transmitted to the next host.
Alternatively, PCD could help in controlling the population of parasites in the host, thereby
increasing host survival and favoring parasite transmission, as proposed by Seed and Wenk.
Therefore, PCD in trypanosomatid parasites may represent a pathway involved both in survival and
propagation of the species.
Programmed cell death in trypanosomatids
The unicellular protozoan parasite Leishmania, Trypano-
soma cruzi and Trypanosoma brucei are the causative agents
responsible for human leishmaniasis, Chagas disease, and
African sleeping sickness, respectively. These trypano-
somatid parasites have complex life cycles that involve
multiple hosts. Inside the insect vector or mammalian
host, these parasites undergo differentiation and multipli-
cation phases. By some unknown signals/mechanisms,
some individuals in the total population differentiate into
non-dividing but infectious forms, predisposed to live
inside the next host. However, the fate of the remaining
non-infectious forms is not known. Are these cells elimi-
nated by a process akin to programmed cell death?
Recently, several reports have provided evidence for a
form of programmed cell death (PCD) in the trypano-
somatid parasites Leishmania,  Trypanosoma cruzi and
Trypanosoma brucei [reviewed in ref. [1]]. We and others
have shown that several features of PCD described in
higher eukaryotes were also found in these trypanosoma-
tid parasites [reviewed in ref. [1]]. These features include
depolarization of mitochondrial membrane potential,
release of cytochrome C, activation of proteases, phos-
phatidyl serine exposure, loss of plasma membrane integ-
rity and DNA fragmentation. Such features have been
observed in parasites in culture in vitro either upon treat-
ment with various stimuli i.e. H2O2, staurosporine,
amphotericin B, or in late stationary phase cultures
[reviewed in ref. [1]]. Further, some of the regulatory and
effector molecules that have similarity to known PCD fac-
tors in either higher eukaryotes or unicellular organisms
also have been identified in trypanosomatids [reviewed in
ref. [1]]. In addition, evidence of PCD has also been
observed in vivo e.g. in dying T. brucei rhodesiense inside
the midgut of tsetse flies [2] or in Leishmania donovani
amastigotes inside macrophages isolated from patients
that were treated with antileishmanial drugs [3].
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Although some similarities with apoptosis of mammalian
cells can be drawn, it is believed that the type of PCD
observed in unicellular trypanosomatids is different from
that described in higher eukaryotes [[1], references there
in]. Whether these differences reflect the remains of an
ancient form of PCD in trypanosomatids that evolved
into the sophisticated apoptosis process in mammalian
cells or the necessary adaptation of unicellular parasites to
survive inside their various hosts remains to be elucidated.
The important question still remaining is what could be
the role of PCD in trypanosomatid parasites. In order to
address this question, it is fair to assume that if unicellular
parasites have retained such a PCD pathway during evolu-
tion, it is because this pathway must be beneficial or
essential for survival of the species or population.
In the case of Leishmania, inside the gut of the sandfly vec-
tor, the procyclic promastigote forms of the parasite mul-
tiply and differentiate into several intermediate forms and
ultimately into infectious metacyclic promastigotes. Only
the infectious metacyclics are transmitted into the mam-
malian host and have the ability to successfully differenti-
ate into amastigotes and establish an infection. Since not
all the promastigotes differentiate into metacyclic forms
inside the gut of the insect, we believe that the remaining
procyclic forms may undergo PCD, as seen in stationary
phase culture in vitro [1]. Such an elimination process of
procyclic forms would be beneficial for the rest of the pop-
ulation (i.e. metacyclics) since these parasites would not
utilize the limited supply of essential nutrients such as
purines or heme (that they are not able to synthesize de
novo) present in the insect gut. Therefore, PCD in the
Leishmania promastigote stage may represent an altruistic
mechanism for the selection of parasites that are fit to
transmit the disease to the mammalian host, which is a
critical step for the propagation of parasites.
Inside the mammalian host, there is a slow multiplication
phase of Leishmania amastigotes (over weeks in the ham-
ster model, or years in the case of human visceral leishma-
niasis) leading to an accumulation of infected
macrophages in the spleen and liver. During this chronic
phase of the disease, one can assume a continuous release
of amastigotes in the infected organs due to the bursting
of infected macrophages. The free extracellular amastig-
otes are then phagocytosed by new macrophages inside
which they multiply. This reinfection cycle occurs without
triggering an overwhelming immune response by the
host, which would be detrimental for the parasite survival.
PCD might play a role in this silencing of the host
immune response since recent findings showed that
uptake of apoptotic T lymphocytes by macrophages
infected with T. cruzi increases parasite growth inside
these macrophages [4]. Such uptake of apoptotic T cells
renders the macrophages refractory to inflammatory
cytokines, a process probably mediated by transforming
growth factor-beta production, and allowing parasite sur-
vival and growth. Since L. donovani amastigotes (axeni-
cally grown) can enter a PCD pathway [1], it is possible
that "apoptotic-like" amastigotes in vivo could also play a
role in silencing the host immune response when they
enter the macrophages along with non-apoptotic amastig-
otes. Such a process could maintain the parasite growth in
the infected tissues during the chronic phase of the dis-
ease. Further, this increased survival of parasites through
the programmed sacrifice of some would improve the
probability of completing their life cycle through the bite
of a sandfly and ultimately resulting in the propagation of
the species.
Such an altruistic behavior of a trypanosomatid parasite is
also proposed by Seed and Wenk in this current issue.
These authors argue that the transition from long slender
(LS) to short stumpy (SS) forms of African trypanosome
parasites in the mammalian host has evolved in part to
help control the parasitemia and to increase host survival
time. These authors show that after transformation from
LS to SS, only a fraction of SS parasites undergo apoptotic-
like events, which lead to their cell death and their stimu-
lation of the host immune system. Unlike Leishmania,
stimulation of the host immune system by SS trypano-
somes undergoing PCD leads to elimination of most of
the parasite population from the host and selection of
minor LS variant and new infective SS forms, which favor
parasite transmission for a longer time by keeping the
host alive.
In conclusion, in order to successfully demonstrate the
real purpose of the PCD, whether altruistic or otherwise,
in Leishmania and other trypanosomatid parasites, it is
essential to first establish PCD in vivo, in an infected host.
In addition, the molecular characterization of effector
molecules that are critical for the parasite PCD pathway is
essential because such process could be exploited for
novel therapeutic intervention.
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